GKB Ophthalmics (NSE:GKB) Loans Receivable: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GKB GKB Ophthalmics Ltd NSE:GKB
44 GF Score
Price ₹63.00
GF Value ₹126.38
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is GKB Ophthalmics Loans Receivable?

GKB Ophthalmics NSE:GKB 44 Loans Receivable is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:GKB with a GF Score™ of 44/100 and a GF Value™ of ₹126.38 (Significantly Undervalued). The stock has 5 warning signs investors should review.

GKB Ophthalmics's Loans Receivable for the quarter that ended in Jun. 2026 was ₹0 Mil.

GKB Ophthalmics Loans Receivable Related Terms

GKB Ophthalmics Loans Receivable Historical Data

* Premium members only.

The historical data trend for GKB Ophthalmics's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GKB Ophthalmics Loans Receivable Chart

GKB Ophthalmics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GKB Ophthalmics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:GKB
44GF Score
GKB Ophthalmics Ltd NSE:GKB
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GKB Ophthalmics Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of ₹0 Mil mean?
GKB Ophthalmics (NSE:GKB) has a Loans Receivable of ₹0 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on GKB Ophthalmics and its competitors.
Is GKB Ophthalmics' Loans Receivable too high?
GKB Ophthalmics' current Loans Receivable is ₹0 Mil. Overall, GKB Ophthalmics has a GF Score™ of 44/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Loans Receivable compare to ISRG and BDX?
GKB Ophthalmics' Loans Receivable of ₹0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Medical Devices & Instruments company?
A good Loans Receivable depends on the Medical Devices & Instruments industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on GKB Ophthalmics and its competitors. GKB Ophthalmics's current Loans Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (NSE:GKB) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹126.38, compared to a current price of ₹63.00 — trading 50.2% below its estimated fair value. The current Loans Receivable is ₹0 Mil. GKB Ophthalmics' overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For GKB Ophthalmics (NSE:GKB), the current Loans Receivable is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GKB Ophthalmics (NSE:GKB) Overvalued in 2026?

Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued. The current stock price of ₹63.00 is trading 50.2% below its estimated GF Value™ of ₹126.38. GuruFocus considers GKB Ophthalmics to be Significantly Undervalued.

Key valuation signals for NSE:GKB:

  • Loans Receivable: ₹0 Mil
  • GF Value™: ₹126.38 vs. price of ₹63.00 (50.2% below fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the NSE:GKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GKB Ophthalmics Business Description

Other Exchanges 533212:India
Address 16-A, Tivim Industrial Estate, Mapusa, GA, IND, 403 526
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
44GF Score

Get the complete analysis for NSE:GKB

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹63.00
Price
₹126.38
GF Value